Related Experiment Video
Updated: Jul 26, 2026

Murine Colitis Modeling using Dextran Sulfate Sodium DSS
Published on: January 19, 2010
Effects of nitidine chloride on ulcerative colitis in mice and its mechanism
Ya-Li Wu1,2, Xin Liu1,2, Kai-Li Liu1,2
1Department of Cell Physiology, Shanxi Medical University.
Objective:
To investigate the protective effects of nitidine chloride (NC) on dextran sodium sulfate (DSS) - induced ulcerative colitis (UC) in mice by targeting miR-31 and its underlying mechanisms.
Methods:
DSS at the concentration of 1% was used to induce UC in mice. Thirty C57BL/6 male mice were randomly divided into four groups: normal control group (n=7), DSS group (n=8), DSS + NC group (7.27 mg/kg) (n=8) and NC group (n=7). DSS was added in drinking water, and NC was administrated by gavage. The period of modeling lasted for 3 weeks. The control group and NC group drank sterile water every day, DSS group and DSS + NC group drank 1% DSS water in the first week, normal water in the second week and 1% DSS water in the third week. In the last week of modeling, mice in control group and DSS group were given 0.5% CMC-Na by gavage, while mice in DSS + NC group and NC group were given NC by gavage. After the establishment of the model, the disease activity index (DAI) related to colitis was observed, the pathological score of colon tissue was evaluated by HE staining, the expression level of miR-31 in colon tissue was detected by qPCR, and the protein expressions of NF -κ B and COX-2 in colon tissue were detected by Western blot.
Results:
① Compared with DSS group, the DAI in the DSS + NC group was decreased (P<0.01). The colonic pathological injury was obviously ameliorated after treated by NC. ② Compared with normal control group, the expression of miR-31 in colonic tissue of DSS group was increased significantly(P<0.01), compared with DSS group, the expression of miR-31 was decreased after treatment with NC(P< 0.05). ③ Compared with DSS group, the levels of inflammatory protein NF-κB and COX-2 in DSS + NC group was decreased significantly (P<0.05).
Conclusion:
Nitidine chloride has obvious therapeutic effects on DSS induced mouse colitis, and its anti-inflammatory mechanism is related to the down-regulation of miR-31 expression.
Insights
Nitidine chloride (NC) effectively treats dextran sodium sulfate (DSS)-induced ulcerative colitis (UC) in mice. NC reduces disease activity and inflammation by down-regulating miR-31 expression, offering a potential therapeutic strategy for UC.
Area of Science:
- Gastroenterology
- Pharmacology
- Molecular Biology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease with limited treatment options.
- Dextran sodium sulfate (DSS)-induced colitis in mice is a widely used model to study UC pathogenesis and test potential therapies.
- MicroRNAs (miRNAs) play crucial roles in regulating inflammatory responses and are implicated in UC.
Purpose of the Study:
- To investigate the protective effects of nitidine chloride (NC) against DSS-induced UC in a mouse model.
- To elucidate the underlying mechanisms of NC's action, focusing on the role of miR-31.
- To evaluate the impact of NC on key inflammatory markers.
Main Methods:
- Ulcerative colitis was induced in C57BL/6 mice using 1% DSS in drinking water.
- Mice were divided into four groups: control, DSS, DSS + NC, and NC.
- NC was administered via gavage, and disease activity index (DAI), colonic pathology (HE staining), miR-31 expression (qPCR), and protein levels of NF-κB and COX-2 (Western blot) were assessed.
Main Results:
- NC treatment significantly decreased the DAI and ameliorated colonic pathological injury in DSS-induced colitis mice.
- DSS administration led to a significant increase in miR-31 expression in colonic tissue, which was reduced by NC treatment.
- NC significantly downregulated the expression of inflammatory proteins NF-κB and COX-2 in the colons of DSS-treated mice.
Conclusions:
- Nitidine chloride exhibits significant therapeutic effects on DSS-induced ulcerative colitis in mice.
- The anti-inflammatory mechanism of NC involves the down-regulation of miR-31 expression.
- NC demonstrates potential as a novel therapeutic agent for ulcerative colitis.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Ulcerative Colitis